What are the causes and treatments of anaphylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Anaphylaxis: Causes and Treatment

Common Causes of Anaphylaxis

The most common triggers of anaphylaxis vary by age: in children, foods (especially peanuts, tree nuts, milk, eggs, fish, and shellfish) predominate, while in adults, medications and stinging insects are the leading causes. 1

Food Triggers

  • Pediatric population: Peanuts, tree nuts, milk, eggs, fish, and shellfish are the most frequent culprits 1
  • Adult population: Shellfish causes the greatest number of anaphylactic episodes 1
  • Food reactions almost always occur immediately after exposure, though symptoms may subside and recur several hours later (biphasic reaction) 1

Medication Triggers

  • Antibiotics: Penicillin and other β-lactam antibiotics are the most common drug triggers 1, 2
  • Cancer chemotherapy: Platinum-containing drugs (cisplatin, carboplatin) are increasingly recognized causes, with some reactions due to the solvent Cremophor-L 1
  • NSAIDs and aspirin: These reactions appear medication-specific, allowing patients to tolerate other NSAIDs 1
  • Radiographic contrast material (RCM): Causes anaphylactoid reactions in 5-8% of patients with conventional high-osmolality agents, though newer low-osmolality agents reduce this risk by approximately 80% 1

Insect Venom

  • Hymenoptera (bees, wasps, hornets) stings cause systemic reactions in 0.5-3.3% of the US population 1
  • Most fatalities occur in patients with no prior history of systemic allergic reactions 1

Other Triggers

  • Latex: Particularly affects healthcare workers, patients with spina bifida, and those with frequent medical procedures 1
  • Physical factors: Exercise, cold, heat, and sunlight can trigger anaphylaxis 1
  • Idiopathic: Up to one-fifth of anaphylaxis cases have no identifiable trigger 1, 3

Risk Factors for Severe or Fatal Anaphylaxis

Major risk factors include prior history of anaphylaxis, β-adrenergic blocker therapy, cardiovascular disease, poorly controlled asthma, older age, and atopic background (for venom and latex). 1

  • β-blocker use: Increases severity and may reduce epinephrine responsiveness 1
  • Asthma: Especially if severe or poorly controlled, significantly increases risk of fatal reactions 1
  • Cardiovascular disease: Associated with more severe outcomes 1
  • Adolescence: Fatal anaphylaxis is often associated with this age group, particularly when combined with delayed epinephrine administration 1
  • Previous RCM reaction: Risk of repeat reaction ranges from 16-44% without prophylaxis 1

Immediate Treatment of Anaphylaxis

Epinephrine administered intramuscularly into the anterolateral thigh is the first-line, life-saving treatment and must be given immediately at the onset of anaphylaxis—when in doubt, give epinephrine. 1, 4, 5

Epinephrine Administration

  • Dosing: 0.01 mg/kg of 1:1000 solution (1 mg/mL) intramuscularly
    • Maximum 0.3 mg in prepubertal children
    • Maximum 0.5 mg in adolescents and adults 1, 4
  • Route: Intramuscular injection into the mid-outer thigh (vastus lateralis muscle) provides optimal absorption 1, 4
  • Repeat dosing: 10-20% of patients require a second dose; repeat every 5-15 minutes if symptoms persist or worsen 1, 4, 5
  • No absolute contraindications: Even patients on β-blockers should receive epinephrine (though they may require glucagon as adjunctive therapy if refractory) 4

Critical Pitfall to Avoid

Delayed epinephrine administration is directly associated with increased hospitalization, hypoxic-ischemic encephalopathy, and death—never substitute antihistamines as first-line treatment. 4

Supportive Measures (After Epinephrine)

  • Patient positioning: Place supine with legs elevated, or in position of comfort if respiratory distress or vomiting present 1
  • Oxygen: Administer supplemental oxygen 1
  • IV fluids: Rapid volume replacement with crystalloids or colloids for hypotension (up to 50% of intravascular volume can shift to extravascular space within 10 minutes) 5
  • Adjunct medications (only after epinephrine):
    • H1 and H2 antihistamines
    • Corticosteroids
    • β2 agonists for bronchospasm
    • Glucagon for patients on β-blockers 1, 3

Observation Period

All patients must be transferred to an emergency department for observation, even if symptoms resolve, due to risk of biphasic reactions. 4, 5

  • Biphasic anaphylaxis occurs in 4-5% of cases, typically 1-72 hours after initial resolution 1, 4
  • Higher risk in patients requiring multiple epinephrine doses 4
  • Observation period should be 4-12 hours depending on severity and risk factors 3

Prevention Strategies

Avoidance and Education

Patient education is the most important preventive strategy, including instruction on hidden allergens, cross-reactions, and proper use of self-administered epinephrine. 1

  • Prescribe epinephrine auto-injector for all patients with history of anaphylaxis 1, 5
  • Patients should wear medical alert identification 1
  • Refer to allergist-immunologist for comprehensive evaluation 5

Specific Prophylaxis Strategies

  • Insect venom immunotherapy: Highly effective (90-98%) for patients with systemic sensitivity to stinging insects 1
  • RCM reactions: Pretreatment with corticosteroids and antihistamines markedly reduces recurrent reactions; use low-osmolality agents 1
  • Medication desensitization: Can be effective for drugs that previously caused anaphylaxis, though effect is temporary and must be repeated if medication needed again 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Anaphylaxis and Anaphylactoid Reactions: Diagnosis and Management.

American journal of therapeutics, 1996

Research

Anaphylaxis: Recognition and Management.

American family physician, 2020

Guideline

Anaphylaxis Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Anaphylaxis Management and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.